Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Joe E. who wrote (5401)	9/25/1998 1:22:00 PM
From: sam	Respond to of 6136

Actually, short interest rose from 7,304,820 to 8,339,202. Go figure...

To: Joe E. who wrote (5401)	9/25/1998 1:23:00 PM
From: JimieA	Respond to of 6136

Something seems wrong with WSJ short interest numbers: Per: viwes.com AGPH Agouron Pharmaceuticals Shares Avg Daily Month Short Volume Ratio 08/98 7,304,820 609,387 11.99 07/98 7,172,117 858,760 8.35 06/98 9,144,403 449,458 20.35 05/98 9,519,722 854,850 11.14

To: Joe E. who wrote (5401)	9/25/1998 1:31:00 PM
From: Steve Fancy	Read Replies (1) \| Respond to of 6136

Joe, I had noticed that, but I suspect the data is in error. Many of the Nasdaq short interest stocks had fallen to near 0 if you look at just the "A"'s. As far as I can tell, August short interest was 7,304,820... viwes.com ...In that I believe Nasdaq short interest is only reported once a month, seems a difference in reporting dates could not account for the discrepancy. I'll bet it's down though. AGPH seems to be holding up nicely so far. Maybe this show will be the turning point. sf